WILLIAMS AND JENSEN, PLLC for ASTRAZENECA PHARMACEUTICALS LP (FORMERLY ASTRAZENECA PHARMACEUTICALS GROUP)
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of Patient Protection and Affordable Care Act. Drug safety and drug counterfeiting. (track and trace)Drug importation; 340B Program; Authorized generics; Drug company patent settlements; Prescription drug advertising; Federal preemption for prescription drugs; drug shortages.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL BEER New | LA, Rep. Dave Hobson |
| JENNY DIJAMES | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| MELINDA M MAXFIELD New | — |
| ERIN BOOK MULLEN New | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | — |
Medicare/Medicaid MMM
Medicare prescription drug benefit. Drug rebates for Medicare Part D. Part D benefit structure. Indpendent Payment Advisory Board (IPAB). House and Senate action on H.J. Res. 59 and possible drug industry issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES | — |
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Veterans VET
Pharmaceutical sourcing from non-Trade Agreement Act countries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW B HOEKSTRA | — |
| GEORGE OLSEN | — |
| ANTHONY J RODA | — |
Foreign Relations FOR
Market access issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC STEWART New | COS and Deputy Asst. Sec., Dept. of Commerce |
Taxation/Internal Revenue Code TAX
Tax issues affecting the pharmaceutical industry, tax reform issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNY DIJAMES | — |
| CHRISTOPHER W HATCHER | — |
| TESS ILLOS | — |
| GEORGE OLSEN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| ASTRAZENECA AB | Sweden | Sweden | 90.3% | — |
| ASTRAZENECA TREASURY LIMITED | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA UK LIMITED | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA INTERMEDIATE HOLDINGS LTD. | United Kingdom | United Kingdom | 100.0% | — |
| ASTRAZENECA PLC | United Kingdom | United Kingdom | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.